{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:18:25Z","timestamp":1779887905449,"version":"3.53.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-024915"],"award-info":[{"award-number":["INV-024915"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-024915"],"award-info":[{"award-number":["INV-024915"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-024915"],"award-info":[{"award-number":["INV-024915"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-024915"],"award-info":[{"award-number":["INV-024915"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-024915"],"award-info":[{"award-number":["INV-024915"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-024915"],"award-info":[{"award-number":["INV-024915"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-024915"],"award-info":[{"award-number":["INV-024915"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-024915"],"award-info":[{"award-number":["INV-024915"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-024915"],"award-info":[{"award-number":["INV-024915"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-024915"],"award-info":[{"award-number":["INV-024915"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-024915"],"award-info":[{"award-number":["INV-024915"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-024915"],"award-info":[{"award-number":["INV-024915"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-024915"],"award-info":[{"award-number":["INV-024915"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-024915"],"award-info":[{"award-number":["INV-024915"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-024915"],"award-info":[{"award-number":["INV-024915"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-024915"],"award-info":[{"award-number":["INV-024915"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-024915"],"award-info":[{"award-number":["INV-024915"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-024915"],"award-info":[{"award-number":["INV-024915"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-10447-7","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:52:11Z","timestamp":1752137531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Monitoring of antibodies against SARS-CoV-2 over 2 years and characterization of immune responses following Omicron infection in a South Indian community cohort"],"prefix":"10.1038","volume":"15","author":[{"given":"Ramya","family":"Madhavan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackwin Sam","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir","family":"Babji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanduni","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poornima","family":"Saravanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajith","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Immanuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishnavi","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akilandeswari","family":"Eswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavithra","family":"Dhanapal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soundari","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isai","family":"Thamizh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagandeep","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"10447_CR1","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/S0140-6736(21)02758-6","volume":"398","author":"SSA Karim","year":"2021","unstructured":"Karim, S. S. A. & Karim, Q. A. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet 398, 2126\u20132128. https:\/\/doi.org\/10.1016\/S0140-6736(21)02758-6 (2021).","journal-title":"Lancet"},{"key":"10447_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41423-021-00836-z","volume":"19","author":"J Hu","year":"2022","unstructured":"Hu, J. et al. Increased immune escape of the new SARS-CoV-2 variant of concern Omicron. Cell. Mol. Immunol. 19, 293\u2013295. https:\/\/doi.org\/10.1038\/s41423-021-00836-z (2022).","journal-title":"Cell. Mol. Immunol."},{"key":"10447_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ijid.2021.12.357","volume":"116","author":"F Abdullah","year":"2022","unstructured":"Abdullah, F. et al. Decreased severity of disease during the first global Omicron variant Covid-19 outbreak in a large hospital in tshwane, South Africa. Int. J. Infect. Dis. 116, 38\u201342. https:\/\/doi.org\/10.1016\/j.ijid.2021.12.357 (2022).","journal-title":"Int. J. Infect. Dis."},{"key":"10447_CR4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","volume":"399","author":"T Nyberg","year":"2022","unstructured":"Nyberg, T. et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 Omicron (B.1.1.529) and delta (B.1.617.2) variants in england: a cohort study. Lancet 399, 1303\u20131312. https:\/\/doi.org\/10.1016\/S0140-6736(22)00462-7 (2022).","journal-title":"Lancet"},{"key":"10447_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s40001-023-01373-3","volume":"28","author":"R Thiruvengadam","year":"2023","unstructured":"Thiruvengadam, R. et al. Clinical and experimental evidence suggest Omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity. Eur. J. Med. Res. 28, 421. https:\/\/doi.org\/10.1186\/s40001-023-01373-3 (2023).","journal-title":"Eur. J. Med. Res."},{"key":"10447_CR6","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-022-04399-5","volume":"602","author":"JM Carre\u00f1o","year":"2022","unstructured":"Carre\u00f1o, J. M. et al. Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron. Nature 602, 682\u2013688. https:\/\/doi.org\/10.1038\/s41586-022-04399-5 (2022).","journal-title":"Nature"},{"key":"10447_CR7","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41586-021-04387-1","volume":"602","author":"S Cele","year":"2022","unstructured":"Cele, S. et al. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature 602, 654\u2013656. https:\/\/doi.org\/10.1038\/s41586-021-04387-1 (2022).","journal-title":"Nature"},{"key":"10447_CR8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","volume":"602","author":"D Planas","year":"2022","unstructured":"Planas, D. et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature 602, 671\u2013675. https:\/\/doi.org\/10.1038\/s41586-021-04389-z (2022).","journal-title":"Nature"},{"key":"10447_CR9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.virs.2022.11.007","volume":"37","author":"T Xiang","year":"2022","unstructured":"Xiang, T., Wang, J. & Zheng, X. The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages. Virol. Sin. 37, 786\u2013795. https:\/\/doi.org\/10.1016\/j.virs.2022.11.007 (2022).","journal-title":"Virol. Sin"},{"key":"10447_CR10","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1038\/s41467-022-32396-9","volume":"13","author":"K Khan","year":"2022","unstructured":"Khan, K. et al. Omicron BA.4\/BA.5 escape neutralizing immunity elicited by BA.1 infection. Nat. Commun. 13, 4686 (2022).","journal-title":"Nat. Commun."},{"key":"10447_CR11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","volume":"608","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature 608, 593\u2013602. https:\/\/doi.org\/10.1038\/s41586-022-04980-y (2022).","journal-title":"Nature"},{"key":"10447_CR12","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1038\/s41591-021-01548-7","volume":"27","author":"KB Pouwels","year":"2021","unstructured":"Pouwels, K. B. et al. Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. Nat. Med. 27, 2127\u20132135. https:\/\/doi.org\/10.1038\/s41591-021-01548-7 (2021).","journal-title":"Nat. Med."},{"key":"10447_CR13","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1016\/j.vaccine.2021.05.063","volume":"39","author":"KA Earle","year":"2021","unstructured":"Earle, K. A. et al. Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine 39, 4423\u20134428. https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.063 (2021).","journal-title":"Vaccine"},{"key":"10447_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cell.2021.12.046","volume":"185","author":"W Dejnirattisai","year":"2022","unstructured":"Dejnirattisai, W. et al. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Cell 185, 467\u2013484. https:\/\/doi.org\/10.1016\/j.cell.2021.12.046 (2022). e15 e415.","journal-title":"Cell"},{"key":"10447_CR15","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1056\/NEJMc2201849","volume":"386","author":"J Yu","year":"2022","unstructured":"Yu, J. et al. Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 variants. N Engl. J. Med. 386, 1579\u20131580. https:\/\/doi.org\/10.1056\/NEJMc2201849 (2022).","journal-title":"N Engl. J. Med."},{"key":"10447_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijid.2023.04.407","volume":"133","author":"KD Zens","year":"2023","unstructured":"Zens, K. D. et al. Longitudinal humoral and cell-mediated immune responses in a population-based cohort in zurich, Switzerland between March and June 2022 \u2013 evidence for protection against Omicron SARS-CoV-2 infection by neutralizing antibodies and spike-specific T-cell responses. Int. J. Infect. Dis. 133, 18\u201326. https:\/\/doi.org\/10.1016\/j.ijid.2023.04.407 (2023).","journal-title":"Int. J. Infect. Dis."},{"key":"10447_CR17","doi-asserted-by":"publisher","first-page":"e632","DOI":"10.1016\/S2666-5247(23)00139-8","volume":"4","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. Viral and antibody dynamics of acute infection with SARS-CoV-2 Omicron variant (B.1.1.529): a prospective cohort study from shenzhen, China. Lancet Microbe. 4, e632\u2013e641. https:\/\/doi.org\/10.1016\/S2666-5247(23)00139-8 (2023).","journal-title":"Lancet Microbe"},{"key":"10447_CR18","doi-asserted-by":"publisher","first-page":"100547","DOI":"10.1016\/j.lanepe.2022.100547","volume":"24","author":"ME Zaballa","year":"2023","unstructured":"Zaballa, M. E. et al. Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in geneva, switzerland: a population-based study. Lancet Reg. Health Eur. 24, 100547. https:\/\/doi.org\/10.0547 (2023).","journal-title":"Lancet Reg. Health Eur."},{"key":"10447_CR19","doi-asserted-by":"publisher","first-page":"e29343","DOI":"10.1016\/j.heliyon.2024.e29343","volume":"10","author":"M Simanavi\u010dius","year":"2024","unstructured":"Simanavi\u010dius, M. et al. Prevalence of SARS-CoV-2-specific antibodies in a sample of the Lithuanian population-based study in spring 2023. Heliyon 10, e29343. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29343 (2024).","journal-title":"Heliyon"},{"key":"10447_CR20","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41467-022-35652-0","volume":"14","author":"K Sun","year":"2023","unstructured":"Sun, K. et al. Rapidly shifting Immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa. Nat. Commun. 14, 246. https:\/\/doi.org\/10.1038\/s41467-022-35652-0 (2023).","journal-title":"Nat. Commun."},{"key":"10447_CR21","doi-asserted-by":"publisher","first-page":"8846953","DOI":"10.1155\/2023\/8846953","volume":"2023","author":"PD Yadav","year":"2023","unstructured":"Yadav, P. D. et al. Broadly reactive SARS-CoV-2-Specific T-cell response and participation of memory B and T cells in patients with Omicron COVID-19 infection. J. Immunol. Res. 2023, 8846953. https:\/\/doi.org\/10.1155\/2023\/8846953 (2023).","journal-title":"J. Immunol. Res."},{"issue":"5","key":"10447_CR22","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3390\/vaccines10050739","volume":"10","author":"P Dhalaria","year":"2022","unstructured":"Dhalaria, P., Arora, H., Singh, A. K., Mathur, M. & Ajith Kumar, S. COVID-19 vaccine hesitancy and vaccination coverage in india: an exploratory analysis. Vaccines (Basel). 10 (5), 739. https:\/\/doi.org\/10.3390\/vaccines10050739 (2022).","journal-title":"Vaccines (Basel)"},{"key":"10447_CR23","doi-asserted-by":"publisher","first-page":"108267","DOI":"10.1016\/j.diabres.2020.108267","volume":"165","author":"R Gupta","year":"2020","unstructured":"Gupta, R. & Misra, A. COVID19 in South asians\/asian indians: heterogeneity of data and implications for pathophysiology and research. Diabetes Res. Clin. Pract. 165, 108267. https:\/\/doi.org\/10.1016\/j.diabres.2020.108267 (2020).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10447_CR24","doi-asserted-by":"publisher","first-page":"e059869","DOI":"10.1136\/bmjopen-2021-059869","volume":"12","author":"R Madhavan","year":"2022","unstructured":"Madhavan, R. et al. Risk of COVID-19 re-infection and its predictors (CORES): protocol for a community-based longitudinal cohort study in vellore, India. BMJ Open. 12, e059869. https:\/\/doi.org\/10.1136\/bmjopen-2021-059869 (2022).","journal-title":"BMJ Open."},{"issue":"1","key":"10447_CR25","doi-asserted-by":"publisher","first-page":"102130","DOI":"10.1016\/j.xpro.2023.102130","volume":"4","author":"A Rouers","year":"2023","unstructured":"Rouers, A., Tay, M. Z., Ng, L. F. P. & Renia, L. B-cell elispot assay to analyze human memory B cell and plasmablast responses specific to SARS-CoV-2 receptor-binding domain. Star. Protoc. 4 (1), 102130 (2023).","journal-title":"Star. Protoc."},{"key":"10447_CR26","doi-asserted-by":"publisher","first-page":"2222849","DOI":"10.1080\/22221751.2023.2222849","volume":"12","author":"A Solastie","year":"2023","unstructured":"Solastie, A. et al. Changes in SARS-CoV-2 Seroprevalence and population immunity in finland, 2020\u20132022. Emerg. Microbes Infect. 12, 2222849. https:\/\/doi.org\/10.1080\/22221751.2023.2222849 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"10447_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41564-021-01051-2","volume":"7","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Longitudinal analysis of antibody dynamics in COVID-19 convalescents reveals neutralizing responses up to 16 months after infection. Nat. Microbiol. 7, 423\u2013433. https:\/\/doi.org\/10.1038\/s41564-021-01051-2 (2022).","journal-title":"Nat. Microbiol."},{"key":"10447_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41586-022-04865-0","volume":"607","author":"RK Suryawanshi","year":"2022","unstructured":"Suryawanshi, R. K. et al. Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination. Nature 607, 351\u2013355. https:\/\/doi.org\/10.1038\/s41586-022-04865-0 (2022).","journal-title":"Nature"},{"key":"10447_CR29","doi-asserted-by":"publisher","first-page":"100453","DOI":"10.1016\/j.lanepe.2022.100453","volume":"20","author":"S Medi\u0107","year":"2022","unstructured":"Medi\u0107, S. et al. Risk and severity of SARS-CoV-2 reinfections during 2020\u20132022 in vojvodina, serbia: A population-level observational study. Lancet Reg. Health Eur. 20, 100453. https:\/\/doi.org\/10.1016\/j.lanepe.2022.100453 (2022).","journal-title":"Lancet Reg. Health Eur."},{"key":"10447_CR30","doi-asserted-by":"publisher","first-page":"801431","DOI":"10.3389\/fimmu.2022.801431","volume":"13","author":"A Mazzoni","year":"2022","unstructured":"Mazzoni, A. et al. SARS-CoV-2 spike-specific CD4\u2009+\u2009T cell response is conserved against variants of concern, including Omicron. Front. Immunol. 13, 801431. https:\/\/doi.org\/10.3389\/fimmu.2022.801431 (2022).","journal-title":"Front. Immunol."},{"key":"10447_CR31","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41586-022-04460-3","volume":"603","author":"R Keeton","year":"2022","unstructured":"Keeton, R. et al. T cell responses to SARS-CoV-2 Spike cross-recognize Omicron. Nature 603, 488\u2013492. https:\/\/doi.org\/10.1038\/s41586-022-04460-3 (2022).","journal-title":"Nature"},{"key":"10447_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1146\/annurev-immunol-101721-061120","volume":"41","author":"A Sette","year":"2023","unstructured":"Sette, A., Sidney, J. & Crotty, S. T cell responses to SARS-CoV-2. Annu. Rev. Immunol. 41, 343\u2013373. https:\/\/doi.org\/10.1146\/annurev-immunol-101721-061120 (2023).","journal-title":"Annu. Rev. Immunol."},{"key":"10447_CR33","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202617","author":"N Le Bert","year":"2021","unstructured":"Le Bert, N. et al. Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection. J. Exp. Med. 218. https:\/\/doi.org\/10.1084\/jem.20202617 (2021).","journal-title":"J. Exp. Med. 218"},{"key":"10447_CR34","doi-asserted-by":"publisher","first-page":"eade6132","DOI":"10.1126\/sciimmunol.ade6132","volume":"9","author":"SH Kim","year":"2024","unstructured":"Kim, S. H. et al. Omicron BA.2 breakthrough infection elicits CD8\u2009+\u2009T cell responses recognizing the Spike of later Omicron subvariants. Sci. Immunol. 9, eade6132. https:\/\/doi.org\/10.1126\/sciimmunol.ade6132 (2024).","journal-title":"Sci. Immunol."},{"issue":"13","key":"10447_CR35","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.3390\/ijms23137155","volume":"23","author":"A Tarke","year":"2022","unstructured":"Tarke, A. et al. Early and polyantigenic CD4 T cell responses correlate with mild disease in acute COVID-19 donors. Int. J. Mol. Sci. 23 (13), 7155. https:\/\/doi.org\/10.3390\/ijms23137155 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"10447_CR36","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1007\/s10875-023-01558-9","volume":"43","author":"D Gra\u00e7a","year":"2023","unstructured":"Gra\u00e7a, D. et al. Both humoral and cellular immune responses to SARS-CoV-2 are essential to prevent infection: a prospective study in a working vaccinated population from Southern France. J. Clin. Immunol. 43, 1724\u20131739. https:\/\/doi.org\/10.1007\/s10875-023-01558-9 (2023).","journal-title":"J. Clin. Immunol."},{"key":"10447_CR37","doi-asserted-by":"publisher","first-page":"ofac362","DOI":"10.1093\/ofid\/ofac362","volume":"9","author":"E Martinuzzi","year":"2022","unstructured":"Martinuzzi, E. et al. Escape of SARS-CoV-2 variant Omicron to mucosal immunity in vaccinated subjects. Open. Forum Infect. Dis. 9, ofac362. https:\/\/doi.org\/10.1093\/ofid\/ofac362 (2022).","journal-title":"Open. Forum Infect. Dis."},{"issue":"2","key":"10447_CR38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/pathogens12020169","volume":"12","author":"SM King","year":"2023","unstructured":"King, S. M., Bryan, S. P., Hilchey, S. P., Wang, J. & Zand, M. S. First impressions matter: immune imprinting and antibody Cross-Reactivity in influenza and SARS-CoV-2. Pathogens 12 (2), 169. https:\/\/doi.org\/10.3390\/pathogens12020169 (2023).","journal-title":"Pathogens"},{"key":"10447_CR39","doi-asserted-by":"publisher","unstructured":"Maltseva, M., Keeshan, A., Cooper, C. & Langlois, M. A. Immune imprinting: the persisting influence of the first antigenic encounter with rapidly evolving viruses. Hum. Vaccin Immunother 20(1):2384192. https:\/\/doi.org\/10.1080\/21645515.2024.2384192","DOI":"10.1080\/21645515.2024.2384192"},{"key":"10447_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/978-1-4419-6451-9_3","volume":"684","author":"O Boyman","year":"2010","unstructured":"Boyman, O., Cho, J. H. & Sprent, J. The role of interleukin-2 in memory CD8 cell differentiation. Adv. Exp. Med. Biol. 684, 28\u201341. https:\/\/doi.org\/10.1007\/978-1-4419-6451-9_3 (2010).","journal-title":"Adv. Exp. Med. Biol."},{"key":"10447_CR41","doi-asserted-by":"publisher","unstructured":"Dan, J. M. et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science 371 https:\/\/doi.org\/10.1126\/science.abf4063 (2021).","DOI":"10.1126\/science.abf4063"},{"key":"10447_CR42","doi-asserted-by":"publisher","first-page":"eabj9853","DOI":"10.1126\/science.abj9853","volume":"374","author":"J Mateus","year":"2021","unstructured":"Mateus, J. et al. Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells. Science 374, eabj9853. https:\/\/doi.org\/10.1126\/science.abj9853 (2021).","journal-title":"Science"},{"key":"10447_CR43","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","volume":"185","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Humoral and cellular immune memory to four COVID-19 vaccines. Cell 185, 2434\u20132451e17. https:\/\/doi.org\/10.1016\/j.cell.2022.05.022 (2022).","journal-title":"Cell"},{"key":"10447_CR44","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.cell.2022.04.009","volume":"185","author":"RR Goel","year":"2022","unstructured":"Goel, R. R. et al. Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine. Cell 185, 1875\u20131887e8. https:\/\/doi.org\/10.1016\/j.cell.2022.04.009 (2022).","journal-title":"Cell"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10447-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10447-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10447-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T03:25:32Z","timestamp":1757215532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10447-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10447"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10447-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study has been approved by the Institutional Review Board of Christian Medical College, Vellore (IRB min no: 13585). We certify that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"24756"}}